Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Nov 3, 2025, 4:00 PM EST
1.750
+0.080 (4.79%)
After-hours: Nov 3, 2025, 7:59 PM EST
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $139.47 million as of November 3, 2025. Its market cap has increased by 81.11% in one year.
Market Cap
139.47M
Enterprise Value
143.27M
1-Year Change
81.11%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $139.47M, an increase of 54.60%. That is a compound annual growth rate of 16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 139.47M | 69.49% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.94B |
| Johnson & Johnson | 448.32B |
| AbbVie | 376.01B |
| UnitedHealth Group | 301.79B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |